"GPR35 protein, mouse"[nm] - Search Results

Year	Number of Results
2006	1
2008	1
2010	1
2012	2
2013	3
2014	1
2017	1
2018	6
2019	4
2020	3
2021	6
2022	7
2023	10
2024	3

1

GPR35: from enigma to therapeutic target.

Milligan G. Milligan G. Trends Pharmacol Sci. 2023 May;44(5):263-273. doi: 10.1016/j.tips.2023.03.001. Epub 2023 Mar 30. Trends Pharmacol Sci. 2023. PMID: 37002007 Review.

2

GPR35 promotes neutrophil recruitment in response to serotonin metabolite 5-HIAA.

De Giovanni M, Tam H, Valet C, Xu Y, Looney MR, Cyster JG. De Giovanni M, et al. Cell. 2022 Mar 3;185(5):815-830.e19. doi: 10.1016/j.cell.2022.01.010. Epub 2022 Feb 10. Cell. 2022. PMID: 35148838 Free PMC article.

3

Mitochondrial remodeling and ischemic protection by G protein-coupled receptor 35 agonists.

Wyant GA, Yu W, Doulamis IP, Nomoto RS, Saeed MY, Duignan T, McCully JD, Kaelin WG Jr. Wyant GA, et al. Science. 2022 Aug 5;377(6606):621-629. doi: 10.1126/science.abm1638. Epub 2022 Aug 4. Science. 2022. PMID: 35926043 Free PMC article.

4

A Gpr35-tuned gut microbe-brain metabolic axis regulates depressive-like behavior.

Cheng L, Wu H, Cai X, Zhang Y, Yu S, Hou Y, Yin Z, Yan Q, Wang Q, Sun T, Wang G, Yuan Y, Zhang X, Hao H, Zheng X. Cheng L, et al. Cell Host Microbe. 2024 Feb 14;32(2):227-243.e6. doi: 10.1016/j.chom.2023.12.009. Epub 2024 Jan 9. Cell Host Microbe. 2024. PMID: 38198925

5

Lysophosphatidic Acid-Mediated GPR35 Signaling in CX3CR1⁺ Macrophages Regulates Intestinal Homeostasis.

Kaya B, Doñas C, Wuggenig P, Diaz OE, Morales RA, Melhem H; Swiss IBD. Cohort Investigators; Hernández PP, Kaymak T, Das S, Hruz P, Franc Y, Geier F, Ayata CK, Villablanca EJ, Niess JH. Kaya B, et al. Cell Rep. 2020 Aug 4;32(5):107979. doi: 10.1016/j.celrep.2020.107979. Cell Rep. 2020. PMID: 32755573 Free article.

6

Kynurenic Acid and Gpr35 Regulate Adipose Tissue Energy Homeostasis and Inflammation.

Agudelo LZ, Ferreira DMS, Cervenka I, Bryzgalova G, Dadvar S, Jannig PR, Pettersson-Klein AT, Lakshmikanth T, Sustarsic EG, Porsmyr-Palmertz M, Correia JC, Izadi M, Martínez-Redondo V, Ueland PM, Midttun Ø, Gerhart-Hines Z, Brodin P, Pereira T, Berggren PO, Ruas JL. Agudelo LZ, et al. Cell Metab. 2018 Feb 6;27(2):378-392.e5. doi: 10.1016/j.cmet.2018.01.004. Cell Metab. 2018. PMID: 29414686 Free article.

7

Aminosalicylates target GPR35, partly contributing to the prevention of DSS-induced colitis.

Otkur W, Wang J, Hou T, Liu F, Yang R, Li Y, Xiang K, Pei S, Qi H, Lin H, Zhou H, Zhang X, Piao HL, Liang X. Otkur W, et al. Eur J Pharmacol. 2023 Jun 15;949:175719. doi: 10.1016/j.ejphar.2023.175719. Epub 2023 Apr 11. Eur J Pharmacol. 2023. PMID: 37054942

8

Recent advances in GPR35 pharmacology; 5-HIAA serotonin metabolite becomes a ligand.

Im DS. Im DS. Arch Pharm Res. 2023 Jun;46(6):550-563. doi: 10.1007/s12272-023-01449-y. Epub 2023 May 25. Arch Pharm Res. 2023. PMID: 37227682 Review.

9

Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment.

Pagano E, Elias JE, Schneditz G, Saveljeva S, Holland LM, Borrelli F, Karlsen TH, Kaser A, Kaneider NC. Pagano E, et al. Gut. 2022 Mar;71(3):509-520. doi: 10.1136/gutjnl-2020-323363. Epub 2021 Mar 23. Gut. 2022. PMID: 33758004 Free PMC article.

10

Discovery of a novel GPR35 agonist with high and equipotent species potency for oral treatment of IBD.

Song Z, Lu D, Sun J, Ye Y, Fang J, Wang K, Guo S, Zhang Q, He X, Xie X, Shen J. Song Z, et al. Bioorg Med Chem. 2023 Dec 15;96:117511. doi: 10.1016/j.bmc.2023.117511. Epub 2023 Nov 1. Bioorg Med Chem. 2023. PMID: 37976806

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

44 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year